Glue, Paul

Effects of Low-Dose and Very Low-Dose Ketamine among Patients with Major Depression: a Systematic Review and Meta-Analysis

Xu, Y., Hackett, M., Carter, G., Loo, C., Gálvez, V., Glozier, N., Glue, P., Lapidus, K., McGirr, A., Somogyi, A. A., et al. (2016) · International Journal of Neuropsychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 226

Pilot Randomized Controlled Trial of Titrated Subcutaneous Ketamine in Older Patients with Treatment-Resistant Depression

George, D., Gálvez, V., Martin, D., Kumar, D., Leyden, J., Hadzi-Pavlovic, D., Harper, S., Brodaty, H., Glue, P., Taylor, R., et al. (2017) · The American Journal of Geriatric Psychiatry

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 149

Ketamine’s dose-related effects on anxiety symptoms in patients with treatment refractory anxiety disorders

Glue, P., Medlicott, N. J., Harland, S., Neehoff, S., Anderson-Fahey, B., Le Nedelec, M., Gray, A., & McNaughton, N. (2017) · Journal of Psychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 144

Meta-analysis of relapse prevention antidepressant trials in depressive disorders

Glue, P., Donovan, M. R., Kolluri, S., & Emir, B. (2010) · Australian & New Zealand Journal of Psychiatry

Treatment of Major DepressionMental Health Treatment and Access

Cited by 100

Safety and efficacy of maintenance ketamine treatment in patients with treatment-refractory generalised anxiety and social anxiety disorders

Glue, P., Neehoff, S. M., Medlicott, N. J., Gray, A., Kibby, G., & McNaughton, N. (2018) · Journal of Psychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 100

Repeated intranasal ketamine for treatment-resistant depression – the way to go? Results from a pilot randomised controlled trial

Gálvez, V., Li, A., Huggins, C., Glue, P., Martin, D., Somogyi, A. A., Alonzo, A., Rodgers, A., Mitchell, P. B., & Loo, C. K. (2018) · Journal of Psychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 85

Ketamine and psychotherapy for the treatment of psychiatric disorders: Systematic review

Kew, B. M., Porter, R. J., Douglas, K. M., Glue, P., Mentzel, C. L., & Beaglehole, B. (2023) · BJPsych Open

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 69

An improved human anxiety process biomarker: Characterization of frequency band, personality and pharmacology

Shadli, S. M., Glue, P., McIntosh, J., & McNaughton, N. (2015) · Translational Psychiatry

Anxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesNeural and Behavioral Psychology Studies

Cited by 68

Oxytocin improves emotion recognition for older males

Campbell, A., Ruffman, T., Murray, J. E., & Glue, P. (2014) · Neurobiology of Aging

Neuroendocrine regulation and behaviorFace Recognition and Perception

Cited by 63

Systematic review and meta-analysis of randomized controlled trials of ketamine in the treatment of refractory anxiety spectrum disorders

Whittaker, E., Dadabayev, A. R., Joshi, S. A., & Glue, P. (2021) · Therapeutic Advances in Psychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 56

Mood and Pain Responses to Repeat Dose Intramuscular Ketamine in a Depressed Patient with Advanced Cancer

Zanicotti, C. G., Perez, D., & Glue, P. (2012) · Journal of Palliative Medicine

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 52

A randomized, double-blind, placebo-controlled phase II trial to explore the effects of a GABAA-α5 NAM (basmisanil) on intellectual disability associated with Down syndrome

Goeldner, C., Kishnani, P. S., Skotko, B. G., Casero, J. L., Hipp, J. F., Derks, M., Hernandez, M.-C., Khwaja, O., Lennon-Chrimes, S., Noeldeke, J., et al. (2022) · Journal of Neurodevelopmental Disorders

Down syndrome and intellectual disability researchAlzheimer's disease research and treatments

Cited by 48

Safety and efficacy of extended release ketamine tablets in patients with treatment-resistant depression and anxiety: open label pilot study

Glue, P., Medlicott, N. J., Neehoff, S., Surman, P., Lam, F., Hung, N., & Hung, C.-T. (2020) · Therapeutic Advances in Psychopharmacology

Treatment of Major DepressionElectroconvulsive Therapy Studies

Cited by 42

Anxiolytic effects of acute and maintenance ketamine, as assessed by the Fear Questionnaire subscales and the Spielberger State Anxiety Rating Scale

Truppman Lattie, D., Nehoff, H., Neehoff, S., Gray, A., & Glue, P. (2021) · Journal of Psychopharmacology

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 13

Infraslow closed-loop brain training for anxiety and depression (ISAD): a protocol for a randomized, double-blind, sham-controlled pilot trial in adult females with internalizing disorders

Perez, T. M., Glue, P., Adhia, D. B., Navid, M. S., Zeng, J., Dillingham, P., Smith, M., Niazi, I. K., Young, C. K., & De Ridder, D. (2022) · Trials

EEG and Brain-Computer InterfacesTranscranial Magnetic Stimulation Studies

Cited by 8

Do Social Isolation and Loneliness Kill People with Alzheimer's Disease?

Barak, Y., & Glue, P. (2018) · OBM Geriatrics

Dementia and Cognitive Impairment ResearchHealth disparities and outcomes

Cited by 4